Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Aurora Cannabis

Aphria

Canopy Growth

Green Thumb Industries Inc.

Top marijuana stocks rose as Virginia lawmakers on Saturday approved legislation that would legalize recreational use of cannabis by 2024. The post Marijuana Stocks Surge As First Southern State OKs Recreational Use appeared first on Investor's Business Daily.

Marijuana Stocks Surge As First Southern State OKs Recreational Use

Arena Pharmaceuticals

Innovative Industrial Properties

Jazz Pharmaceuticals

SNDL Inc.

Village Farms International

cbdMD Inc

Welcome back to our weekly series, Sc haeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will continue to develop in the 2021.

8 Red-Hot Pot Stocks Toughing Out Last Week's Winter Weather

TLRY stock is already having an amazing 2021, but it's only the beginning. The Tilray-Aphria merger is expected to close in the second quarter of the year.

Tilray Is Gathering Momentum for a Profitable 2021

AMC Entertainment

BlackBerry

Bed Bath & Beyond

Express

Koss

Nokia

Zomedica

GameStop

The rallies in January's meme stocks clearly went too far. After big pullbacks, however, some of the names may still have a long-term case.

How to Navigate the Questionable Future of the Top 10 Meme Stocks

Cronos Group

The cannabis sector has yet to completely shed its reputation of being part of the "wild, wild west," but much has changed, T3 Ventures President Tahira Rehmatullah said Thursday during Benzinga's virtual Cannabis Capital Conference.  Cannabis operators with plenty of experience have likely at some point entered into a deal where there was no model or the depth that was needed, Rehmatullah said.

Why The Stigma Around Cannabis Investments Is 'Gone'

HEXO Corp

OrganiGram Holdings Inc.

Institutional investors and hedge fund managers were "seeing green" in the fourth quarter.

5 Pot Stocks Money Managers Bought Hand Over Fist in Q4

The bubble pop is moving quickly from sector to sector as marijuana stocks took center stage in one of the biggest and quickest to rise and fall recently. The post 7 Marijuana Stocks That Could Still Go Down in Flames appeared first on InvestorPlace.

7 Marijuana Stocks That Could Still Go Down in Flames

The AdvisorShares Pure US Cannabis ETF has surpassed $1 billion in assets under management, according to a company statement released Tuesday. The ETF, which trades under the ticker MSOS, launched on September 2, 2020 and has grown from $2.5 million in assets to now $1 billion in just six months. The fund has returned 110% since its inception and 37% in 2021 alone. The AdvisorShares ETF was the first US exchange traded fund to focus solely on American cannabis companies and multi-state operations (MSOs), or companies directly involved in the legal production and distribution of cannabis.  The fund's inflows are a sign of growing investor interest in the cannabis space amid speculation that the Biden administration will keep its campaign promises and decriminalize marijuana. Some Democrats in Congress have pushed even further, advocating for the full legalization of cannabis in the US.

The first US cannabis ETF surpassed $1 billion in AUM in its first 6 months of trading

Shareholders Encouraged to Visit Joint Company Website for Information About the Proposed Aphria-Tilray Combination Anti-Trust Clearances Received and Transaction Remains On-Track to Close in the Second Quarter of 2021 LEAMINGTON, ON and NANAIMO, BC, Feb. 23, 2021 /PRNewswire/ - Aphria...

Aphria and Tilray Announce Launch of www.aphriatilraytogether.com

Curaleaf Holdings, Inc.

Constellation Brands

Trulieve Cannabis Corp.

These five marijuana stocks are for careful, conservative investors. They each have safe financial traits for those who like to play it safe.

5 Marijuana Stocks for the Conservative Investor

GrowGeneration Corp

With many people seeking natural therapies to address pandemic-related stress, the backdrop is favorable for marijuana stocks. The post 8 Medical Marijuana Stocks That Are Just What the Doctor Ordered appeared first on InvestorPlace.

8 Medical Marijuana Stocks That Are Just What the Doctor Ordered

The ETFMG Alternative Harvest ETF (NYSE: MJ) traded lower on Monday as investors continued to take profits on the post-election run-up in cannabis stocks. This week is a big week in the cannabis space with several potential catalysts of note ahead.

4 Things Cannabis Investors Should Watch This Week

Not long ago, the company's prospects were grim. Now TLRY stock is a darling of Wall Street.

Tilray Stock Has Shown Lots of Progress, but the Valuation Is Frothy

Marijuana stocks have outpaced the broader market so far this year and the gains could continue as retail investors pile in. The post 4 Marijuana Stocks That Are Surging appeared first on InvestorPlace.

4 Marijuana Stocks That Are Surging

Amplify Seymour Cannabis ETF

Amplify Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

Global X Cannabis ETF

AXS Cannabis ETF

Cambria Cannabis ETF

AdvisorShares Vice ETF

AdvisorShares Pure Cannabis ETF 

Michael Auerbach returns to discuss Subversive's recent deal with leading Israeli cannabis company, InterCure, and gives an update on The Parent Company. Why Subversive pivoted from a REIT to a SPAC, Canndoc's compelling financials, brands and trading on Nasdaq.

SPAC Week II: Canndoc And The Parent Company (Podcast Transcript)

The ETFMG Alternative Harvest ETF (NYSE: MJ) rebounded by 3.1% on Friday to around $25, but the find is still way off its February high of near $35. On Friday, DataTrek Research co-founder Jessica Rabe discussed what drove the early 2021 cannabis stock rally and three reasons why it has run out of steam in the past two weeks.

3 Reasons Cannabis Stocks May Be Headed Lower

After achieving EBITDA positivity and with an upcoming merger with Aphria, Tilray is poised to do well in the coming year. The post Tilray Will Be the Largest Cannabis Company Once It Merges With Aphria appeared first on InvestorPlace.

Tilray Will Be the Largest Cannabis Company Once It Merges With Aphria

GW Pharmaceuticals

New Age Beverages

9 Red-Hot Cannabis Stocks Blazing This Week

Both are high-flying Canadian pot stocks. But one appears to have a clear edge.

Better Cannabis Stock: Sundial Growers vs. Tilray

Analysts say the marijuana producer's shares may have come too far, too fast.

Why Tilray Stock Plunged Today

CNBC's cannabis expert Tim Seymour discusses the outlook for the industry.

Should You Invest in Marijuana Stocks & ETFs Now?

Brendan Kennedy, CEO of cannabis giant Tilray Inc. (NASDAQ:TLRY), posted a letter to his employees after the company hosted its most recent earnings call.  In the letter, Kennedy emphasized the 26% revenue spike in 2020 (compared to 2019) and reiterated that the Nanaimo, Canada-based company is ripe for growth once it wraps up its

Tilray CEO Touts Many 'Cannabis Firsts' In Glowing Letter To Employees After Earnings Call

An earnings beat and beaten down share price add value to a well-placed vertical strategy in TLRY stock for investors. The post Why and How to Buy a Tilray Earnings Beat appeared first on InvestorPlace.

Why and How to Buy a Tilray Earnings Beat

Tilray Inc. shares fell on Thursday, as analysts weighed in on the company's latest quarterly earnings with most looking ahead to the company's pending merger with Aphria Inc., saying Tilray looks less compelling on its own.

Cannabis Watch: Tilray stock loses steam as analysts say company not compelling as stand-alone business, look to Aphria deal

Canadian cannabis companies Tilray Inc. (NASDAQ: TLRY) and Aphria Inc. (NASDAQ: APHA) have agreed to a merger. Meanwhile, Tilray announced strong fourth-quarter results, with meaningful revenue growth and margin expansion.

Tilray Analysts On The Sidelines Despite Solid Earnings

News for Tilray Brands Stock (TLRY)